Reoxygenation during radiotherapy in intermediate-risk prostate cancer.
Supiot S, Rousseau C, Dore M, Chèze-Le-Rest C, Kandel-Aznar C, Potiron V, Guerif S, Paris F, Ferrer L, Campion L, Meingan P, Delpon G, Hatt M, Visvikis D.
Supiot S, et al. Among authors: potiron v.
Radiother Oncol. 2019 Apr;133:16-19. doi: 10.1016/j.radonc.2018.12.022. Epub 2019 Jan 12.
Radiother Oncol. 2019.
PMID: 30935573